In a study at the 33rd EADV Congress 2024, on cutaneous squamous cell carcinoma (cSCC), leading experts from across Europe and the United States convened

This session was presented at the 33rd EADV Congress at Amsterdam by Drs Elisa Crystal Sanchez Moreno et al from Dermacenter, Jalisco, Mexico A groundbreaking

This study was presented at the 33rd EADV Congress at Amsterdam by Drs Matthew Zirwas, Mark Boguniewicz et al from Dermatologists of the Central States,

This trial result was presented at the 33rd EADV Congress at Amsterdam by Drs Neal Koller, Gary Pekoe et al from the University of Sydney,

This trial results was presented at the 33rd EADV Congress at Amsterdam by Drs Arash Mostaghimi, Brett King, Maryanne M. Senna et al from the

This study was presented at the 33rd EADV Congress at Amsterdam by Dr Iftikhar Sheikh from Alhamd Skin Clinics Lahore Pakistan. A recent study has

At the last day of the 33rd EADV Congress 2024, leading experts gathered to discuss the latest findings on melasma and hyperpigmentation, shedding light on

At the 33rd EADV Congress held in Amsterdam, leading experts gathered to discuss the latest developments in acne treatment, focusing on new guidelines, the use

This trial was presented at the 33rd EADV Congress at Amsterdam by Drs Brett King et al from Yale School of Medicine, New Haven, CT,

This study was presented at the 33rd EADV Congress at Amsterdam by Drs James Q. Del Rosso, Thu Nguyen, and Krzysztof Piotrowski et al from